Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-01

Clinical Trial Update: Text to Move (TTM)Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Text to Move (TTM) in Type 2 Diabetes Mellitus completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED